Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 73Breast Neoplasms 70Colorectal Neoplasms 39Prostatic Neoplasms 37Carcinoma, Non-Small-Cell Lung 26Lung Neoplasms 25Stomach Neoplasms 20Carcinoma, Hepatocellular 20Uterine Cervical Neoplasms 19Pancreatic Neoplasms 15Anxiety Disorders 15Leukemia, Myeloid, Acute 14Hematologic Neoplasms 13Colonic Neoplasms 13Brain Neoplasms 13Urinary Bladder Neoplasms 12Lymphoma, Follicular 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Head and Neck Neoplasms 11Esophageal Neoplasms 10Diabetes Mellitus 10Ovarian Neoplasms 9Melanoma 9Liver Neoplasms 9Sarcoma 8Rectal Neoplasms 8Pulmonary Disease, Chronic Obstructive 8Multiple Myeloma 8Esophageal Squamous Cell Carcinoma 8Disease 8

Interventions

selinexor 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × MDS × Clear all
NCT06664970 2024-10-30

A Multicenter Study on the Treatment of MDS/MPN Overlap Syndrome With AZA or Rux Combined With Selinexor

Peking Union Medical College Hospital

Phase 2 Enrolling by invitation
39 enrolled

MDS

Data powered by HemOnc (CC BY 4.0) Colophon âš¡